Figure S1 from Antitumor Activity of Trastuzumab Deruxtecan in Pediatric Solid Tumors with Variable HER2 Expression

2026 Open access

Read full text
Authors: Chelsey Burke, Tamar Y. Feinberg, Samantha Brosius, Umesh Kumar Bhanot, Mala Jain, Irina Linkov, Armaan H. Siddiquee, Kristina C. Guillan, Glorymar Ibáñez, Andoyo A. Ndengu, Paul Calder, Néstor Rosales
+11 more Diego F. Coutinho, Matthew M. Long, Raina Fishkin, Sheeno P. Thyparambil, Julia L. Glade Bender, Damon R. Reed, Daoqi You, Michael Vincent Ortiz, Emily Kanaya Slotkin, Andrew L. Kung, Filemon S. Dela Cruz
DOI: 10.1158/1535-7163.30986048
Cited by: 0

Fields of Study & Subjects

HER2/EGFR in Cancer Research Peptidase Inhibition and Analysis Cancer therapeutics and mechanisms

Publication details

Publication date
2 January 2026